Seeking Alpha

Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an...

Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application is a continuation of its earlier patent, and broadens its claims by guaging the drugs effects against a subject's own baseline, as well as on a patient population basis. An earlier application granted last week had been guaged only against a placebo control group.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|